Dutogliptin
- Generic Name
- Dutogliptin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C10H20BN3O3
- CAS Number
- 852329-66-9
- Unique Ingredient Identifier
- 38EAO245ZX
- Background
Dutogliptin has been investigated for the treatment of Diabetes Mellitus, Type II.
- Associated Conditions
- -
- Associated Therapies
- -
Long-term Extension Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus
- Conditions
- First Posted Date
- 2010-04-12
- Last Posted Date
- 2010-08-11
- Lead Sponsor
- Phenomix
- Target Recruit Count
- 339
- Registration Number
- NCT01101945
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone
- First Posted Date
- 2010-03-19
- Last Posted Date
- 2011-09-21
- Lead Sponsor
- Forest Laboratories
- Target Recruit Count
- 141
- Registration Number
- NCT01089790
- Locations
- ๐บ๐ธ
Forest Investigative Site 061, Anaheim, California, United States
๐บ๐ธForest Investigative Site 129, Hollywood, Florida, United States
๐บ๐ธForest Investigative Site 156, Boca Raton, Florida, United States
Safety and Efficacy Study of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin
- First Posted Date
- 2009-10-20
- Last Posted Date
- 2010-08-11
- Lead Sponsor
- Phenomix
- Target Recruit Count
- 650
- Registration Number
- NCT00998686
- Locations
- ๐จ๐ฟ
Phenomix Investigational Site 208, Praha 10, Czech Republic
๐ต๐ฑPhenomix Investigational Site 300, Gdansk, Poland
๐ต๐ฑPhenomix Investigational Site 306, Pulawy, Poland
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone
- First Posted Date
- 2009-09-02
- Last Posted Date
- 2011-09-21
- Lead Sponsor
- Forest Laboratories
- Target Recruit Count
- 252
- Registration Number
- NCT00970424
- Locations
- ๐บ๐ธ
Forest Investigative Site 028, Virginia Beach, Virginia, United States
๐บ๐ธForest Investigative Site 032, Kettering, Ohio, United States
๐บ๐ธForest Investigative Site 099, Arlington, Texas, United States
Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal Impairment
- Conditions
- Interventions
- First Posted Date
- 2009-08-13
- Last Posted Date
- 2010-02-03
- Lead Sponsor
- Phenomix
- Target Recruit Count
- 360
- Registration Number
- NCT00958269
- Locations
- ๐บ๐ธ
Phenomix Investigational Site 107, Columbia, South Carolina, United States
๐บ๐ธPhenomix Investigational Site 116, Pembroke Pines, Florida, United States
๐ท๐บPhenomix Investigational Site 203, Moscow, Russian Federation
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin
- First Posted Date
- 2009-07-28
- Last Posted Date
- 2011-09-21
- Lead Sponsor
- Forest Laboratories
- Target Recruit Count
- 677
- Registration Number
- NCT00947557
- Locations
- ๐บ๐ธ
Forest Investigative Site 061, Anaheim, California, United States
๐บ๐ธForest Investigative Site 156, Boca Raton, Florida, United States
๐บ๐ธForest Investigative Site 018, Sarasota, Florida, United States
Long-term Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus
- Conditions
- First Posted Date
- 2009-03-19
- Last Posted Date
- 2010-08-11
- Lead Sponsor
- Phenomix
- Target Recruit Count
- 450
- Registration Number
- NCT00865592
- Locations
- ๐ฆ๐ท
Phenomix Investigational Site 110, Buenos Aires, Argentina
๐ฆ๐ทPhenomix Investigational Site 106, Caba, Argentina
๐ฆ๐ทPhenomix Investigational Site 112, Corrientes, Argentina
Safety and Efficacy Study of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin
- First Posted Date
- 2009-02-24
- Last Posted Date
- 2010-08-11
- Lead Sponsor
- Phenomix
- Target Recruit Count
- 700
- Registration Number
- NCT00850239
- Locations
- ๐บ๐ธ
Phenomix Investigational Site 112, Greenville, South Carolina, United States
๐ฆ๐ทPhenomix Investigational Site 406, Buenos Aires, Argentina
๐ฆ๐ทPhenomix Investigational Site 401, Buenos Aires, Argentina
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.